Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01GTV
|
||||
| Drug Name |
Iobenguane I-123 - GE Healthcare
|
||||
| Synonyms |
123I-Iobenguane; 123I-mIBG; 3-iodobenzylguanidine I-123; AdreView; Iobenguane I<SUP>123</SUP> Injection; Metaiodobenzylguanidine I-123 - GE Healthcare
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Unspecified | Approved | [1] | ||
| Formula |
C8H10IN3
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Modulator | [2] | |
| PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
| Reactome | Na+/Cl- dependent neurotransmitter transporters | ||||
| WikiPathways | Monoamine Transport | ||||
| NRF2 pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
| References | |||||
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
| REF 2 | 2008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.